News & Articles

Discover a solution that can help you ensure your data is accurate and consistent

Multi-centre study published in New England Journal of Medicine suggests CAR-T therapy could improve outcome in B-cell lymphoma patients

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

Advanced analytical quality control and multi-sample visualization included in LIMS system upgrade

Excellent safety profile reported so far, results expected summer 2019

We interview a scientist whose team designed AAV vectors used in a successful gene therapy clinical trial, and highlight the key technologies that supported his efforts

Study results recently published in the international journal of Caner could improve global public health by enabling more precise and specific screening for HPV

Collaboration unites a worldwide leader in the clinical diagnostics industry with one of the nation’s top research and healthcare institutions to address today’s healthcare challenges

Largest African genetics resource presented at ASHG 2018 annual meeting

HeartMate 3 offers significant advancements for patients not eligible for a heart transplant

Clinical study results suggest individuals with type I or II diabetes may achieve improved glycaemic control with Tresiba

This intelligent surgical device is a cornerstone in the surgical removal of cancers

The test supports international guidelines for treating antibiotic resistant STI

The National Center for Tumor Diseases and Protagen AG collaborate to improve information integration

Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors

Novel drug, aducanumab, successfully attacks and clears amyloid β protein deposits

How ddPCR technology could enable earlier therapeutic intervention in EGFR mutated lung cancers

People who suffer a stroke caused by bleeding in the brain could be helped by four simple checks of their brain scans, research suggests

Collaborative research effort reduces off-target CRISPR-Cas9 genome editing, removing barriers for human therapeutic applications

The first non-radioactive dual-tracer for sentinel lymph node biopsy approved in the U.S